The Make in Odisha Conclave 2025, themed ‘Utkarsh Odisha,’ is set to position the state as a hub for economic and industrial growth. Among the various sectors being emphasized, healthcare has taken center stage, with Odisha taking significant steps to attract investment and strengthen its medical infrastructure.
Strengthening Healthcare Infrastructure
One of the primary focuses of the conclave is the development of a pharmaceutical hub in Odisha. The state government has initiated plans to establish this hub to attract pharmaceutical companies and promote indigenous manufacturing. A specialized cell has been formed to develop the Odisha Pharmaceutical Policy 2025, which aims to create a conducive ecosystem for the growth of the pharmaceutical sector.
Investment Opportunities in Healthcare
The conclave includes dedicated sessions focusing on healthcare investments, encouraging stakeholders to explore opportunities in the medical sector. Key areas of interest include hospital infrastructure, medical device manufacturing, biotechnology, and telemedicine. These initiatives align with Odisha’s vision to improve healthcare accessibility and affordability for its citizens.
Promoting Research and Innovation
To foster innovation, Odisha is seeking collaborations with leading healthcare institutions, research centers, and private players. The state aims to enhance R&D facilities and introduce advanced medical technologies that can contribute to better patient care and diagnostic capabilities.
Future Prospects
With government-backed policies and strategic planning, the Make in Odisha Conclave 2025 is expected to attract substantial investments in the healthcare sector. These efforts will not only boost economic growth but also ensure improved healthcare services for the people of Odisha, making the state a leading player in India’s healthcare industry.
As Odisha continues its journey toward industrial excellence, its focus on healthcare is a testament to its commitment to building a healthier and more prosperous future for all.
